Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets
Protein & Cell · 20.06.2025 · 16 (6) · 391-417
DOI: 10.1093/procel/pwae039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Protein & Cell, online erschienen am 10.08.2024. Verfasst von Hao Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Healt…. Hauptthemen laut MEDLINE: Adenosine, Inosine, RNA Editing, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Shenzhen-Hong Kong-Macao Science and Technology Program.
Abstract (Originalsprache)
Adenosine-to-inosine (A-to-I), one of the most prevalent RNA modifications, has recently garnered significant attention. The A-to-I modification actively contributes to biological and pathological processes by affecting the structure and function of various RNA molecules, including double-stranded RNA, transfer RNA, microRNA, and viral RNA. Increasing evidence suggests that A-to-I plays a crucial role in the development of human disease, particularly in cancer, and aberrant A-to-I levels are closely associated with tumorigenesis and progression through regulation of the expression of multiple oncogenes and tumor suppressor genes. Currently, the underlying molecular mechanisms of A-to-I modification in cancer are not comprehensively understood. Here, we review the latest advances regarding the A-to-I editing pathways implicated in cancer, describing their biological functions and their connections to the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, SAR 518172…
ORCID-Profile: Hao Cheng, Jun Yu, Chi Chun Wong
Förderung
- Health and Medical Research Fund
- Shenzhen-Hong Kong-Macao Science and Technology Program
Zitieren
APA
Cheng, H., Yu, J., & Wong, C. C. (2025). Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets. Protein & Cell, 16(6), 391-417. https://doi.org/10.1093/procel/pwae039
Vancouver
Cheng H, Yu J, Wong CC. Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets. Protein & Cell. 2025;16(6):391-417. doi:10.1093/procel/pwae039
BibTeX
@article{Cheng2025,
author = {Cheng, Hao and Yu, Jun and Wong, Chi Chun},
title = {Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets},
journal = {Protein & Cell},
year = {2025},
volume = {16},
number = {6},
pages = {391--417},
doi = {10.1093/procel/pwae039}
}
EUVIMED